Liraglutide downregulates hepatic LDL receptor and PCSK9...

Cardiovascular Diabetology 2018 / 12 Vol. 17; Iss. 1

Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism

Yang, Sheng-Hua, Xu, Rui-Xia, Cui, Chuan-Jue, Wang, Yin, Du, Ying, Chen, Zhi-Guo, Yao, Yu-Hong, Ma, Chun-Yan, Zhu, Cheng-Gang, Guo, Yuan-Lin, Wu, Na-Qiong, Sun, Jing, Chen, Bu-Xing, Li, Jian-Jun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-018-0689-9
Date:
December, 2018
File:
PDF, 1.81 MB
english, 2018
Conversion to is in progress
Conversion to is failed